This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization.

The PolyPeptide Group and OLIGO

Share this article

In an interview at the TIDES USA conference in San Diego, Calif., Trishul Shah, director of business development at PolyPeptide Group, speaks about the company’s expansion into oligonucleotide manufacturing alongside its existing peptide manufacturing and why it was a natural fit to diversify. Shah also shares PolyPeptide Group’s plans to expand its plant in California to accommodate future growth and customer demand.

Share this article

Upcoming event

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum

19 - 21 Mar 2024, Kyoto, Japan

THE ONLY EVENT IN ASIA FOR OLIGO, PEPTIDE, mRNA, GENOME EDITING & DELIVERY EXPERTS TO EXCHANGE STRATEGIES TO ACCELERATE MOLECULES TO MARKET

Go to site